Alzheimer's Disease: RNA Regulation

RNA regulation involves several mechanisms that are used by cells to decrease or increase the production of RNA. Disruption of RNA regulatory processes has been associated with Alzheimer's disease (AD). Here are the latest discoveries pertaining to RNA regulation and AD.

April 14, 2021
Open Access

Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components.

Neuron
E. LesterRoy Parker
April 12, 2021
Open Access

In silico Analysis of Polymorphisms in microRNAs Deregulated in Alzheimer Disease.

Frontiers in Neuroscience
Mahta MoraghebiPegah Mousavi
April 8, 2021
Open Access

Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage.

Nature Communications
Zhongbo ChenMina Ryten
April 10, 2021
Open Access

The emerging role of non-coding RNAs from extracellular vesicles in Alzheimer's disease.

Journal of Integrative Neuroscience
Yu-Zhong XuYu Hu
April 5, 2021
Open Access

Protein interactome of the Cancerous Inhibitor of protein phosphatase 2A (CIP2A) in Th17 cells.

Current Research in Immunology
Mohd Moin KhanRiitta Lahesmaa
April 5, 2021
Open Access

Exploring Common Therapeutic Targets for Neurodegenerative Disorders Using Transcriptome Study.

Frontiers in Genetics
S Akila Parvathy DharshiniM Michael Gromiha
April 4, 2021
Review
Open Access

Astrocytes in Alzheimer's Disease: Pathological Significance and Molecular Pathways.

Cells
Pranav PremanAmaia M Arranz
April 3, 2021
Open Access

Different miRNA Profiles in Plasma Derived Small and Large Extracellular Vesicles from Patients with Neurodegenerative Diseases.

International Journal of Molecular Sciences
Daisy SprovieroCristina Cereda
March 29, 2021

TUFM is involved in Alzheimer's disease-like pathologies that are associated with ROS.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Bi-Rou ZhongGuo-Jun Chen
March 27, 2021
Open Access

A conserved role for the ALS-linked splicing factor SFPQ in repression of pathogenic cryptic last exons.

Nature Communications
Patricia M GordonCorinne Houart
March 18, 2021
Review

The emerging role of exosomes in Alzheimer's disease.

Ageing Research Reviews
Tongmei ZhangYouming Lu
March 14, 2021
Review
Open Access

Neurodegeneration and epigenetics: A review.

Neurología : publicación oficial de la Sociedad Española de Neurología
P Ghosh, A Saadat

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-rna-regulation/cf295a8b-d130-4ba5-9e4e-222d91a713df